| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/26/2006 | WO2006111616A1 Peptide vaccine for influenza virus |
| 10/26/2006 | WO2006111085A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients |
| 10/26/2006 | WO2006111019A1 Mutant f. tularensis strain and uses thereof |
| 10/26/2006 | WO2006084210A9 Hif modulating compounds and methods of use thereof |
| 10/26/2006 | WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 10/26/2006 | WO2005102301A3 Hydroxymethylbutyrate compositions and uses thereof |
| 10/26/2006 | WO2003006628A3 Nad synthetase inhibitors and uses thereof |
| 10/26/2006 | WO2002101008A3 Intracellular signaling molecules |
| 10/26/2006 | US20060241182 Antibiotic, functional cosmetic and functional food containing levulinic acid and their derivatives |
| 10/26/2006 | US20060241177 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 10/26/2006 | US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation |
| 10/26/2006 | US20060241112 Kinase inhibitors |
| 10/26/2006 | US20060241103 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope |
| 10/26/2006 | US20060241087 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity |
| 10/26/2006 | US20060241081 Antiviral for RNA or DNA viruses such as HIV, HBV or HSV; acyclic pyrimidine nucleoside phosphonate analogues; 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidine; ; alkylating the 6-hydroxypyrimidine base with a dialkyl 2-chloroethoxymethylphosphonate |
| 10/26/2006 | US20060241060 10-Acetoxymethyl-2'O-acetyl-10,11-anhydro-10-desmethyl-6 O-methyl-descladinosyl-erythromycin A, for example; bactericides |
| 10/26/2006 | US20060241031 Assay |
| 10/26/2006 | US20060241026 Novel cyclic peptides and use thereof as anti-microbial agents |
| 10/26/2006 | US20060241024 Intermediate for preparing glycopeptide derivatives |
| 10/26/2006 | US20060240528 Polyketides and their synthesis |
| 10/26/2006 | US20060240525 Factor VII or VIIa - Like Molecules |
| 10/26/2006 | US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 10/26/2006 | US20060240446 Novel human cytomegalovirus DNA sequences |
| 10/26/2006 | US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 10/26/2006 | US20060240123 Pharmaceutical composition |
| 10/26/2006 | US20060240119 Pharmacologically active strong acid solutions |
| 10/26/2006 | US20060240118 Pharmacologically active strong acid solutions |
| 10/26/2006 | US20060240115 Composition against injection with and process for producting the same |
| 10/26/2006 | US20060240053 cosmetic or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one purified natural or synthetic polypeptide wherein the peptide sequence is represented wholly or partly by at least one sequence |
| 10/26/2006 | US20060240042 genetic vaccines; Gag, Pol, Pro, Tat, Nef, Rev, Vif, Vpr or Env antigens |
| 10/26/2006 | US20060240041 PRRSV Vaccines |
| 10/26/2006 | US20060240039 Vaccines |
| 10/26/2006 | US20060240034 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 10/26/2006 | US20060240028 Anti-nls substances and uses thereof in nuclear import inhibition |
| 10/26/2006 | US20060240023 Apoptosis-associated protein and use thereof |
| 10/26/2006 | US20060240019 Antagonists of HMG1 for treating inflammatory conditions |
| 10/26/2006 | US20060240011 Use of nf-kappa b inhibitors for the treatment of mastitis |
| 10/26/2006 | US20060240010 Methods of modulating CD200 receptors |
| 10/26/2006 | US20060239993 Containing a mutant angiotensin-converting enzyme that releases glycosylphosphatidylinositol-anchored protein from cell surfaces; for treating a prion-related disease, a bacterial infectious disease or male infertility due to sperm-egg binding insufficiency |
| 10/26/2006 | US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections |
| 10/26/2006 | US20060239990 Protein Arginine N-Methyltransferase 2 (PRMT-2) |
| 10/26/2006 | US20060239936 Delivery of anti-migraine compounds through an inhalation route |
| 10/26/2006 | DE10242476B4 Antibiotikum-/Antibiotika-Polymer-Kombination Antibiotic / polymer combination |
| 10/26/2006 | DE102005020105A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for the preparation of medicament to treat e.g. cancer, autoimmune disease, cardiovascular disease stenosis and infection disease |
| 10/26/2006 | DE102005020104A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for the preparation of medicament to treat e.g. cancer, autoimmune disease, cardiovascular disease stenosis and infection disease |
| 10/26/2006 | CA2606673A1 Mutant f. tularensis strain and uses thereof |
| 10/26/2006 | CA2606180A1 C. perfringens alpha toxoid vaccine |
| 10/26/2006 | CA2605960A1 Nutritional supplement for hiv patients |
| 10/26/2006 | CA2605414A1 Nutritional supplement with colostrum and epa or dha or gla |
| 10/26/2006 | CA2605210A1 Nutritional supplement for a category of hiv patients |
| 10/26/2006 | CA2605010A1 Uronic acid and probiotics |
| 10/26/2006 | CA2604909A1 Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen |
| 10/26/2006 | CA2603833A1 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires |
| 10/26/2006 | CA2602610A1 Benzimidazole compound |
| 10/25/2006 | EP1715064A1 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
| 10/25/2006 | EP1715046A2 New polypeptide, DNA encoding the polypeptide, recombinant vector bearing the DNA and recombinant virus utilizing the recombinant vector as well as use thereof |
| 10/25/2006 | EP1714981A2 Method for the identification of antigenic peptides |
| 10/25/2006 | EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 10/25/2006 | EP1714974A2 HIV-1-and HIV-2-peptides for inhibition of membranes fusion-associated events, including HIV transmission |
| 10/25/2006 | EP1714970A1 Use of inhibitors of RNAse A-family enzymes for stabilizing oligonucleotides having RNA interfering activity |
| 10/25/2006 | EP1714969A2 Immunostimulatory nucleic acid molecules |
| 10/25/2006 | EP1714966A1 Naphthylidine derivative having hiv integrase inhibitory activity |
| 10/25/2006 | EP1714676A2 Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
| 10/25/2006 | EP1714660A1 Uronic acid and probiotics |
| 10/25/2006 | EP1714648A1 Combination drug |
| 10/25/2006 | EP1713917A2 Pneumolysin derivatives |
| 10/25/2006 | EP1713823A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713822A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713785A1 Halogenated biaryl heterocyclic compounds and methods of making and using the same |
| 10/25/2006 | EP1713776A1 Quinoline derivatives for use as mycobacterial inhibitors |
| 10/25/2006 | EP1713772A1 Novel piperidines as chemokine modulators (ccr) |
| 10/25/2006 | EP1713541A1 Use of alkaline phosphatase for the detoxification of lps |
| 10/25/2006 | EP1713481A2 Novel uses for proton pump inhibitors |
| 10/25/2006 | EP1713480A2 The use of quaternary pyridinium salts as vasoprotective agents |
| 10/25/2006 | EP1713478A1 Compositions comprising hiv protease inhibitor and cytochrome p450 enzyme activity inhibitor |
| 10/25/2006 | EP1713477A2 Combination of voriconazole and an antifungal cyp2c19 inhibitor |
| 10/25/2006 | EP1713470A1 Therapeutic combinations |
| 10/25/2006 | EP1669357A4 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof |
| 10/25/2006 | EP1509231A4 Peritoneal dialysis solution with taurolidine |
| 10/25/2006 | EP1458718B1 Quinolinones as prostaglandin receptor ligands |
| 10/25/2006 | EP1423417B1 Antibodies recognizing a peptide mimicking a cryptic epitope of gp41 of hiv-1 |
| 10/25/2006 | EP1409525B1 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 10/25/2006 | EP1377275B1 Vaccine for modulating between t1 and t2 immune responses |
| 10/25/2006 | EP1373308B1 Antagonist for multimerization of hiv-1 vif protein |
| 10/25/2006 | EP1370543B1 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 10/25/2006 | EP1332155B1 Immunization of dairy cattle with gapc protein against streptococcus infection |
| 10/25/2006 | EP1265606B1 Cell adhesion inhibitors |
| 10/25/2006 | EP1187613B9 Amide substituted imidazoquinolines |
| 10/25/2006 | EP0973802B1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses |
| 10/25/2006 | CN1852920A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 10/25/2006 | CN1852915A Purine nucleoside analogues for treating flaviviridae including hepatitis c |
| 10/25/2006 | CN1852729A Antibacterial drug for propionibacterium acnes |
| 10/25/2006 | CN1852709A Macrophage activation inhibitor |
| 10/25/2006 | CN1852708A Human beta-defensin secretion promoter |
| 10/25/2006 | CN1850972A Sialic acid oligose-chitosan complex, and its preparing method and use |
| 10/25/2006 | CN1850861A Anti white spot virus adherent protein VP19 monocloral antibody, and its preparing method |
| 10/25/2006 | CN1850860A Antifish lymphocystis virus capsid protein monoclonal antibody, and its preparing method |
| 10/25/2006 | CN1850845A 3beta, 5 alpha, 6 beta, 11 beta tetrahydroxy cholestanol, and its preparing method and use |
| 10/25/2006 | CN1850839A Dirithromycin water-soluble salt |
| 10/25/2006 | CN1850823A Quinolone compound containing oximino, and its preparing method and use |